Similar articles

• Effectivity and safety of mannitol treatment for acute hepatic failure in rats.

  Watanabe A, Tsuchida T, Shiota T, Tominaga S. Watanabe A, et al. Res Exp Med (Berl). 1992;192(6):401-6. doi: 10.1007/BF02576297. Res Exp Med (Berl). 1992. PMID: 1480817
• Effect of duration of osmotherapy on blood-brain barrier disruption and regional cerebral edema after experimental stroke.

  Chen CH, Toung TJ, Sapirstein A, Bhardwaj A. Chen CH, et al. J Cereb Blood Flow Metab. 2006 Jul;26(7):951-8. doi: 10.1038/sj.jcbfm.9600248. Epub 2005 Nov 23. J Cereb Blood Flow Metab. 2006. PMID: 16306935
• Cerebral edema in the rat with galactosamine induced severe hepatitis.

  Gröflin UB, Thölen H. Gröflin UB, et al. Experientia. 1978 Nov 15;34(11):1501-3. doi: 10.1007/BF01932376. Experientia. 1978. PMID: 720486
• [Current status of brain edema therapy].

  Müchler HC. Müchler HC. Anasthesiol Intensivmed Prax. 1974;9(1):107-13. Anasthesiol Intensivmed Prax. 1974. PMID: 4618984 Review. German. No abstract available.
• [Medicinal substances used for alleviation of cerebral edema-swelling (review of the literature)].

  Kvitnitskiĭ-Ryzhov IuN, Beliavskiĭ VG. Kvitnitskiĭ-Ryzhov IuN, et al. Farmakol Toksikol. 1973 Sep-Oct;36(5):628-31. Farmakol Toksikol. 1973. PMID: 4150866 Review. Russian. No abstract available.